Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashExchange Rate EffectFree Cash FlowGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash Items
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioLineRx (BLRX) Change in Cash: 2023-2025

Historic Change in Cash for BioLineRx (BLRX) over the last 2 years, with Jun 2025 value amounting to -$2.3 million.

  • BioLineRx's Change in Cash fell 158.36% to -$2.3 million in Q2 2025 from the same period last year, while for Jun 2025 it was -$3.0 million, marking a year-over-year decrease of 696.58%. This contributed to the annual value of $6.2 million for FY2024, which is 200.83% up from last year.
  • Latest data reveals that BioLineRx reported Change in Cash of -$2.3 million as of Q2 2025, which was down 72.91% from -$1.3 million recorded in Q1 2025.
  • In the past 5 years, BioLineRx's Change in Cash ranged from a high of $3.9 million in Q2 2024 and a low of -$3.7 million during Q4 2023.
  • Moreover, its 3-year median value for Change in Cash was -$1.1 million (2024), whereas its average is -$354,600.
  • In the last 5 years, BioLineRx's Change in Cash spiked by 218.34% in 2024 and then crashed by 178.27% in 2025.
  • Quarterly analysis of 3 years shows BioLineRx's Change in Cash stood at -$3.7 million in 2023, then skyrocketed by 139.25% to $1.4 million in 2024, then slumped by 158.36% to -$2.3 million in 2025.
  • Its Change in Cash stands at -$2.3 million for Q2 2025, versus -$1.3 million for Q1 2025 and $1.4 million for Q4 2024.